A Prospective Study of I.V. Vinflunine in the Treatment of Patients with Advanced or Metastatic Urothelial Carcinoma after Failure of a Platinum-containing Regimen and Biomarker Correlates
Background: Vinflunine is the only cytotoxic agent that had been tested as a second line therapy in platinum refractory urothelial carcinoma patients in a phase III clinical trial. The aim of our study was to evaluate the efficacy and safety of vinflunine as a second line after failure of platinum c...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
West Asia Organization for Cancer Prevention
2022-08-01
|
| Col·lecció: | Asian Pacific Journal of Cancer Biology |
| Matèries: | |
| Accés en línia: | http://www.waocp.com/journal/index.php/apjcb/article/view/726 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|